A Proof of Concept Study to Assess The Efficacy and Safety of Single Intralesional Doses of DUR-928 in Psoriasis Patients.
Phase of Trial: Phase I
Latest Information Update: 19 Dec 2016
At a glance
- Drugs DUR 928 (Primary) ; Triamcinolone
- Indications Plaque psoriasis
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- 17 Dec 2016 Status changed from recruiting to completed.
- 13 Sep 2016 Status changed from not yet recruiting to recruiting.
- 12 Aug 2016 New trial record